Matinas BioPharma Inc.
MTNB | AMEX
$1.51
-$0.39 (-20.53%)
At close: Oct 30, 2026, 3:59 PM ET
$1.19
-$0.32 (-21.19%)
Pre-market:
Nov 2, 2026, 6:02 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.69M | -10.61M | -10.35M | -16.87M | -19.61M | -20.08M | -24.25M | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M | -20.67M | -20.53M | -21M | -24.06M | -25.44M | -24.31M | -23.28M | -22.92M | -21.54M | -22.36M |
Depreciation & Amortization | 754K | 730K | 784K | 608K | 517K | 856K | 968K | 961K | 959K | 952K | 941K | 926.82K | 918.82K | 915.82K | 898.35K | 877.64K | 843.68K | 795.46K | 781.49K | 767.33K | 759.91K | 773.69K |
Stock-Based Compensation | 574K | 708K | 1.02M | 1.05M | 1.76M | 2.52M | 3.2M | 4.22M | 4.45M | 4.67M | 4.95M | 3.68M | 3.89M | 3.9M | 2.63M | 3.7M | 3.35M | 3.19M | 4.29M | 4.44M | 4.33M | 4.22M |
Other Working Capital | -1.07M | -1.31M | -1.73M | -932K | -1.26M | 758K | 288K | -527K | -24K | 630K | 1.77M | -1.77K | -1.31M | -3.47M | -4.47M | -1.12M | -1.4M | 1.05M | 945.13K | 236.89K | 1.08M | 239.46K |
Other Non-Cash Items | -670K | 3.44M | 3.04M | 7.4M | 7.62M | 4.02M | 4.33M | 6K | 16K | 82K | 108K | 1.49M | 1.52M | 1.54M | 3.1M | 1.79M | 3.01M | 3.01M | 1.45M | 1.62M | 356.88K | 302.57K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -387K | -877K | -1.51M | -1.2M | -1.33M | 567K | -131K | -1.01M | -390K | 588K | 1.67M | 175.79K | -1.21M | -4.31M | -4.79M | -1.12M | -1.36M | 1.98M | 1.53M | 525.82K | 1.04M | -292.22K |
Operating Cash Flow | -6.42M | -6.61M | -7.01M | -9.01M | -11.04M | -12.12M | -15.89M | -16.95M | -17.87M | -16.96M | -15.28M | -15M | -15.55M | -18.49M | -19.16M | -18.81M | -19.59M | -15.33M | -15.22M | -15.57M | -15.05M | -17.35M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -218K | -218K | -259.6K | -493.6K | -346.6K | -891.16K | -885.75K | -859.94K | -804.94K | -260.39K | -218.44K | 5.74K | 5.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -8.44M | -8.44M | -8.44M | -8.44M | n/a | n/a | n/a | -412 | -412 | -6.99M | -9.48M | -14.89M | -25.55M | -21.61M | -23.19M | -15.69M | -11.57M | -14.98M |
Sales Maturities Of Investments | n/a | n/a | n/a | 500K | 10.65M | 15.65M | 17.65M | 20.11M | 11.06M | 12.46M | 13.46M | 10.5M | 15.4M | 12.25M | 15.25M | 20.75M | 25.88M | 33.33M | 40.23M | 41.72M | 34.35M | 38.1M |
Other Investing Acitivies | 335K | 335K | 335K | 320K | 7.94M | n/a | n/a | n/a | -7.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.75K | -5.75K | -5.75K |
Investing Cash Flow | 335K | 335K | 335K | 820K | 10.15M | 7.21M | 9.21M | 11.67M | 3.11M | 12.24M | 13.24M | 10.24M | 14.91M | 4.92M | 4.88M | 4.98M | -531.54K | 10.91M | 16.77M | 25.8M | 22.78M | 23.12M |
Debt Repayment | -8K | -8K | -9K | -3K | -5K | -5K | -5K | -5K | -4K | -4K | -7K | -10.2K | -12.2K | -17.2K | -19.73K | -21.92K | -27.24K | -29.4K | -30.85K | -32.28K | -34.57K | -42.71K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -27K | -29K | -29K | -29K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1 | 1 | 1.21M | 1.7M | 1.77M | 1.77M |
Financial Cash Flow | 121K | 1.74M | 3.39M | 3.33M | 3.2M | 10.77M | 9.17M | 9.17M | 9.24M | 50K | -7K | -10.64K | -12.64K | -17.64K | 79.27K | 92.01K | 86.68K | 273.16K | 6.96M | 7.51M | 7.57M | 7.39M |
Net Cash Flow | -5.96M | -4.53M | -3.29M | -4.86M | 2.31M | 5.85M | 2.5M | 3.89M | -5.53M | -4.67M | -2.04M | -4.77M | -655.84K | -13.59M | -14.2M | -13.75M | -20.04M | -4.14M | 8.51M | 17.74M | 15.3M | 13.21M |
Free Cash Flow | -6.42M | -6.61M | -7.01M | -9.01M | -11.04M | -12.12M | -15.89M | -16.95M | -17.89M | -17.18M | -15.5M | -15.26M | -16.04M | -18.83M | -20.05M | -19.7M | -20.45M | -16.13M | -15.48M | -15.79M | -15.04M | -17.35M |
Adj. Free Cash Flow | -6.99M | -7.31M | -8.03M | -10.06M | -12.8M | -14.64M | -19.08M | -21.18M | -22.34M | -21.85M | -20.44M | -18.93M | -19.94M | -22.73M | -22.68M | -23.4M | -23.8M | -19.32M | -19.78M | -20.23M | -19.37M | -21.57M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -218K | -218K | -218K | -202K | n/a | -544.56K | -580.75K | -804.94K | -804.94K | -260.39K | -212.7K | 11.49K | 11.5K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41.6K | -291.6K | -346.6K | -346.6K | -305K | -55K | n/a | n/a | -5.75K | -5.75K | -5.75K |
Owner Earnings | -6.42M | -6.61M | -7.01M | -9.01M | -11.04M | -12.12M | -15.89M | -16.95M | -17.89M | -17.18M | -15.5M | -15.22M | -15.75M | -18.49M | -19.7M | -19.4M | -20.4M | -16.13M | -15.48M | -15.79M | -15.04M | -17.34M |
Add to Watchlist
Select watchlists to add or remove MTNB